Soleno Therapeutics Inc. (SLNO) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Soleno Therapeutics Inc.

    NASDAQ: SLNO · Real-Time Price · USD
    64.96
    2.24 (3.57%)
    At close: Sep 26, 2025, 3:59 PM
    64.76
    -0.31%
    After-hours: Sep 26, 2025, 04:54 PM EDT

    Soleno Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -10.27 -17.03 -4.09 -5.53
    PEG Ratio
    		 -0.12 6.87 0.07 -0.11
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 7.37 4.21 8.03 9.19
    P/FCF Ratio
    		 -26.05 -26.62 -4 -5.88
    P/OCF Ratio
    		 -26.14 -26.62 -4 -5.89
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.22 0.00 0.01 0.03
    Quick Ratio
    		 15.68 14.89 2.14 2.80
    Current Ratio
    		 15.68 14.89 2.14 2.80
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 -0.72 -0.25 -1.96 -1.66
    Return on Assets
    		 -0.53 -0.22 -0.77 -0.83
    Return on Invested Capital
    		 -0.59 -0.24 -1.06 -1.07
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist